AgomAb Therapeutics NV (AGMB): 6-K filed Sep 14, 2026

Form type

6-K

Filing date

Sep 14, 2026

Accession number

0001104659-26-107500

Filer

AgomAb Therapeutics NV (CIK 2020932)